Precision medicine program for diabetes in China
Precision Medicine of Diabetes Program in China
Second Xiangya Hospital of Central South University · NCT06320600
This study is testing a new way to better classify and diagnose diabetes in patients in China to help create more personalized treatment plans.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 120000 (estimated) |
| Sex | All |
| Sponsor | Second Xiangya Hospital of Central South University (other) |
| Locations | 1 site (Changsha, Hunan) |
| Trial ID | NCT06320600 on ClinicalTrials.gov |
What this trial studies
This observational study aims to enhance the precision classification and diagnosis of diabetes patients by utilizing both retrospective and prospective cohort studies. It seeks to establish a model for accurate diabetes classification and diagnosis, leveraging big data and multi-omics analysis to explore the underlying pathogenesis of diabetes. The goal is to improve individualized treatment approaches and predictive methods for managing diabetes effectively.
Who should consider this trial
Good fit: Ideal candidates for this study are patients diagnosed with diabetes according to WHO 1999 criteria.
Not a fit: Patients who have had diabetes for more than one year or those without a proper medical history may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could lead to more accurate diagnoses and personalized treatment plans for diabetes patients.
How similar studies have performed: Other studies focusing on precision medicine in diabetes have shown promise, indicating that this approach could yield beneficial results.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients diagnosed with diabetes according to WHO 1999 criteria Exclusion Criteria: * with duration more than 1 year; Diabetes has not been diagnosed by WHO standards in 1999; Absence of medical history data
Where this trial is running
Changsha, Hunan
- the Second Xiangya Hospital — Changsha, Hunan, China (RECRUITING)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Diabetes